Compound Detail
CHEMBL4459692
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4459692 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | AVCXUODHLRZJJP-UHFFFAOYSA-N |
6
Targets
7
Activities
1
Assay Types
9
PK Parameters
16
Publications
0
Known Names
Molecular Properties
334.3
MW (Da)
4.46
ALogP
5
HBA
1
HBD
89.4
PSA (Ų)
0.59
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 7 meas. best 8.72
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Retinoic acid receptor beta CHEMBL3266 | EC50 | 8.72 | 8.72 | 1.9 | 1 |
| Retinoic acid receptor beta CHEMBL2008 | EC50 | 8.71 | 8.7 | 1.9 | 2 |
| Retinoic acid receptor gamma CHEMBL2003 | EC50 | 7.96 | 7.96 | 11.0 | 1 |
| Retinoic acid receptor gamma CHEMBL4177 | EC50 | 7.89 | 7.89 | 13.0 | 1 |
| Retinoic acid receptor alpha CHEMBL2055 | EC50 | 7.58 | 7.58 | 26.0 | 1 |
| Retinoic acid receptor alpha CHEMBL2792 | EC50 | 7.58 | 7.58 | 26.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 1.0 | uL/min | Homo sapiens |
| CL | 0.06167 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.01833 | mL.min-1.kg-1 | Canis lupus familiaris |
| F | 40.0 | % | Rattus norvegicus |
| F | 40.0 | % | Canis lupus familiaris |
| T1/2 | 1.4 | hr | Rattus norvegicus |
| T1/2 | 2.5 | hr | Canis lupus familiaris |
| Tmax | 1.7 | hr | Rattus norvegicus |
| Tmax | 1.0 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30792038 | 10.1016/j.bmcl.2019.02.011 | ADMET | 23 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | Unchecked | 5 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | Salmonella typhimurium | 3 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | Retinoic acid receptor beta | 2 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | Rattus norvegicus | 2 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | CHO-K1 | 2 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | Retinoic acid receptor alpha | 1 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | Retinoic acid receptor gamma | 1 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | No relevant target | 1 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | Cytochrome P450 1A2 | 1 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | Cytochrome P450 2C9 | 1 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | Cytochrome P450 2C19 | 1 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | Cytochrome P450 2D6 | 1 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | Cytochrome P450 3A4 | 1 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | HepG2 | 1 |
| 30792038 | 10.1016/j.bmcl.2019.02.011 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
Data from ChEMBL 36 via Core Engine